Investors Press Releases Cardiol Therapeutics to Webcast Annual General Meeting on June 12 June 10, 2019 Cardiol Therapeutics’ Pharmaceutical Partner Noramco Presents at U.S. FDA Public Hearing on CBD June 03, 2019 Cardiol Therapeutics Commences Trading on the OTCQX May 30, 2019 Cardiol Therapeutics Announces Filing of Year-End Financial Statements and MD&A March 28, 2019 Cardiol Therapeutics to Present at the 2019 LD Micro Virtual Conference March 12, 2019 Cardiol Therapeutics Appoints Thomas Moffatt as Chief Commercial Officer March 06, 2019 Cardiol Therapeutics Inc. Closes Over-Allotment January 18, 2019 Cardiol Therapeutics Completes Initial Public Offering and the Company’s Common Shares and Warrants Commence Trading on the Toronto Stock Exchange Under the Symbols “CRDL” and “CRDL.WT” December 20, 2018 Cardiol Therapeutics Appoints Mr. Chris Waddick as Chief Financial Officer, Ms. Anne Tomalin as Director of Regulatory Affairs, and Ms. Dolly Kao as Intellectual Property Counsel August 30, 2018 Cardiol Therapeutics Appoints Dr. Eldon Smith as Chairman and Dr. Guillermo Torre-Amione, Ms. Deborah Brown, and Mr. Iain Chalmers to its Board of Directors August 21, 2018 Page 2 of 4«1234»
